4.5 Article Proceedings Paper

Baseline modern medical management in the BEST-CLI trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

A meta-analysis of randomized controlled trials evaluating the efficacy of smoking cessation interventions in people with peripheral artery disease

Shivshankar Thanigaimani et al.

Summary: This review systematically analyzed the effectiveness of smoking cessation interventions in patients with PAD. The results showed that previous interventions have not been effective in helping PAD patients quit smoking. Further research is needed to develop interventions that can effectively assist PAD patients in smoking cessation.

JOURNAL OF VASCULAR SURGERY (2022)

Article Cardiac & Cardiovascular Systems

Canadian Cardiovascular Society 2022 Guidelines for Peripheral Arterial Disease

Beth L. Abramson et al.

Summary: This article summarizes the evidence and provides recommendations for the diagnosis, risk stratification, medical and intervention treatments for patients with peripheral artery disease (PAD). Strong recommendations based on high-quality evidence include smoking cessation interventions, structured exercise programs, lipid modifying therapy, antithrombotic therapy, treatment of hypertension, and sodium glucose cotransporter 2 inhibitors for diabetes.

CANADIAN JOURNAL OF CARDIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Understanding Study Drug Discontinuation Through EUCLID

E. Hope Weissler et al.

Summary: The study analyzed data from EUCLID and showed that over a quarter of PAD patients prematurely and permanently discontinued study drugs, which was associated with geography, baseline characteristics, and worse outcomes in clinical trials.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Geriatrics & Gerontology

Black-White Disparities in Social and Behavioral Determinants of Health Index and Their Associations with Self-rated Health and Functional Limitations in Older Adults

Taeho Greg Rhee et al.

Summary: The study found that black older adults in the United States have a higher mean cumulative risk score for social and behavioral determinants of health compared to white older adults, and they are more likely to report poorer health status. Black older adults are more likely to report lower self-rated health than white older adults, regardless of SDoH risk factors, but those with high risk factors are more likely to report functional limitations in both racial groups.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2021)

Article Endocrinology & Metabolism

Major adverse limb events in type 2 diabetes patients receiving glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: A retrospective multi-institutional study

Fu-Chih Hsiao et al.

Summary: This study aimed to compare the risk of MALEs between T2DM patients who initiated GLP-1 RAs versus SGLT2Is, and found that patients who received GLP-1 RAs treatment had a lower risk of MALEs.

DIABETES RESEARCH AND CLINICAL PRACTICE (2021)

Review Medicine, General & Internal

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

Suetonia C. Palmer et al.

Summary: This network meta-analysis evaluated the effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes at varying cardiovascular and renal risk levels. The study found that both classes of drugs lowered mortality and improved cardiovascular outcomes, with notable differences in effects between the two agents. Additional benefits and adverse effects varied across different risk groups.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Peripheral Vascular Disease

Medical therapy for cardiovascular and limb-related risk reduction in critical limb ischemia

Stefanos Giannopoulos et al.

Summary: This review examines guideline-recommended therapies for cardiovascular and limb-related risk reduction in patients with Critical Limb Ischemia (CLI).

VASCULAR MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

Racial and Ethnic Disparities in Peripheral Artery Disease

Eddie L. Hackler et al.

Summary: Peripheral artery disease disproportionately affects Black Americans and they are less likely to be diagnosed and treated promptly, leading to grim consequences. The review discusses the risk factors of the disease and how they differentially affect certain groups, providing a resource of available recommendations for clinical management.

CIRCULATION RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Epidemiology of Peripheral Artery Disease and Polyvascular Disease

Aaron W. Aday et al.

Summary: PAD is increasingly recognized as a major cause of cardiovascular morbidity and mortality worldwide. The focus on PAD in recent years has led to new epidemiological insights and highlighted the importance of polyvascular disease in cardiovascular research and clinical practice. PAD may present similar or even greater risk compared to coronary artery disease or stroke.

CIRCULATION RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Contemporary Medical Management of Peripheral Artery Disease

Marc P. Bonaca et al.

Summary: Peripheral artery disease (PAD) is a manifestation of systemic atherosclerosis with modifiable risk factors including smoking, dyslipidemia, and diabetes. Medical therapies can reduce the risk of major adverse cardiovascular events and major adverse limb events, and improve function. Diagnosis and treatment should consider the individual risk profile of the patient.

CIRCULATION RESEARCH (2021)

Article Cardiac & Cardiovascular Systems

Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease

Connie N. Hess et al.

Summary: The study found suboptimal use of LLT, elevated levels of LDL-C, and poor correlation between LLT intensity and achieved LDL-C in PAD patients. Less aggressive lipid management was observed in PAD compared to cardiovascular disease, indicating missed opportunities for implementing proven therapies in PAD.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Review Hematology

Evidence-Based Medical Management of Peripheral Artery Disease

Graham H. Bevan et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Article Medicine, General & Internal

Rivaroxaban in Peripheral Artery Disease after Revascularization

Marc P. Bonaca et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Hematology

Epidemiology and Risk of Amputation in Patients With Diabetes Mellitus and Peripheral Artery Disease

J. Aaron Barnes et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Article Peripheral Vascular Disease

2020 International Society of Hypertension global hypertension practice guidelines

Thomas Unger et al.

JOURNAL OF HYPERTENSION (2020)

Article Surgery

The BEST-CLI trial is nearing the finish line and promises to be worth the wait

Alik Farber et al.

JOURNAL OF VASCULAR SURGERY (2019)

Article Surgery

Global vascular guidelines on the management of chronic limb-threatening ischemia

Michael S. Conte et al.

JOURNAL OF VASCULAR SURGERY (2019)

Article Medicine, General & Internal

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

J. W. Eikelboom et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease

William R. Hiatt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease

Debbie C. Chen et al.

AMERICAN JOURNAL OF CARDIOLOGY (2017)

Article Cardiac & Cardiovascular Systems

Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence

Holger Reinecke et al.

EUROPEAN HEART JOURNAL (2015)

Article Medicine, General & Internal

Hypertension

Neil R. Poulter et al.

LANCET (2015)